WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

CDE Annual Report Reveals Strong Growth and Evolving Focus in China's New Drug... The CDE has released its Annual Report on the Progress of Clinical Trials for New Drug Registration in China (2024), highlighting continued growth in trial activity, evol...
(6/19/2025)

Analyzing Key Trends in China’s Patent-Linkag... (6/27/2025)

Fresh Antitrust Guidelines to Address Pharmace... (6/27/2025)

Breaking the Boundaries: A New Map of Physicia... (6/25/2025)

Structuring Cross Border China Biotech 'NewCo'... (6/19/2025)

CDE Annual Report Reveals Strong Growth and Ev... (6/19/2025)

China Emerges as Prime Global Target for Multi... (6/17/2025)

China Proposes Shorter Clinical Trial Reviews ... (6/16/2025)

China's AI Healthcare Market (Part II): Opport... (6/12/2025)

China's AI Healthcare Market (Part I): Growth ... (6/12/2025)

Following FDA's Elsa, China Accelerates AI Hea... (6/9/2025)

China Ascends to Global Leadership in Oncology... (6/5/2025)

Mainland Chinese Market for Weight Loss and Di... (6/5/2025)

Recent Official and Executive Moves (6/28/2025) China Releases Draft Medical Security La... (6/28/2025) China Raises Per Capita Public Health Fu... (6/28/2025) Innovent Wins Landmark China Approval fo... (6/28/2025) I-Mab Unveils Encouraging Givastomig Res... (6/28/2025) Arbutus and Qilu End Partnership as Arbu... (6/27/2025) Theravance Partner Viatris Lands NMPA Ap... (6/27/2025) Mabwell Strikes Major $596M Deal with Ca... (6/27/2025) Bayer and Tsinghua University Extend 16-... (6/27/2025) CARsgen Submits NDA for Satri‑cel, Pois... (6/27/2025) Vor Bio Secures ex-China Global Rights t... (6/26/2025) BrightGene Seeks Partner for Obesity Dru... (6/26/2025) Immvira Advances Toward HKSE Listing wit... (6/26/2025) China Issues Guidelines to Promote TCM a... (6/24/2025) IASO Bio Highlights CAR-T MS Study Resul... (6/24/2025) Bio-Thera Expands Latin America Biosimil... (6/24/2025) BrightGene Reports Strong Phase 2 Result... (6/24/2025) Aclaris Launches Phase 1a/1b Study of AT... (6/24/2025)

China's Retail Pharmacy Market Hits CNY 941.1B in 2024 ... NH's DB6: China's Consumer Healthcare Market Underperfo... China's Hospital Drug Market Shows Slight Growth in 202... China Unveils Ambitious Plan to Boost Health-Related Co... Chinese VMS OTC Market Growth Slowed to 2.7% in 2024

Innovent Wins Landmark China Approval for Obesity Drug ... Bayer and Tsinghua University Extend 16-Year Partnershi... Mabwell Strikes Major $596M Deal with Calico to Advance... Arbutus and Qilu End Partnership as Arbutus Regains Ful... Immvira Advances Toward HKSE Listing with Focus on Onco...

CDE Issues the Technical Guidelines for IVRT and IVPT o... CDE Solicits Comments on the Draft ICH Guideline E21:... CDE Solicits Comments on the Draft ICH Guideline E21: ... CDE Solicits Comments on the Draft Technical Guidelines... CDE Solicits Comments on the Application Dossier Requir...

China Raises Per Capita Public Health Funding to Suppor... China Issues Guidelines to Promote TCM and Western Medi... China Issues 2025 Action Plan to Combat Malpractice in... NHSA Issues Notice to Enhance Drug Pricing and Procurem... China's Child Health Improves: NHC Official

China Releases Draft Medical Security Law for Public Co... Tianjin Slaps CNY 362M Fine for Drug Price-Fixing Sche... Gavi Launches $224M Arbitration Claim Against Clover Bi... AstraZeneca Faces Escalating Legal Challenges in China ... BeiGene Secures Key Patent Victory in Brukinsa Dispute ...

FDA Issues Warning Letters to Two Chinese API Manufactu... Implications of China's Growing Influence in Global Pha... FDA Issues Warning to Tianjin Darentang for Manufacturi... Shanghai Pharma Considers API Partnerships with Indian ... Aurobindo Challenges China in the Global Penicillin G M...

I-Mab Unveils Encouraging Givastomig Results in First-L... CARsgen Submits NDA for Satri‑cel, Poised to Be First ... Theravance Partner Viatris Lands NMPA Approval for YUPE... Aclaris Launches Phase 1a/1b Study of ATI-052 BrightGene Reports Strong Phase 2 Results for Dual Agon...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Official and Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Former CFDA Commissioner Bi Jingquan Under Investigati...

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...